Enhanced syphilis screening among HIV-positive men (ESSAHM): a study protocol for a clinic-randomized trial with stepped wedge design

Ann N Burchell, Vanessa G Allen, Ramandip Grewal, Paul A MacPherson, Anita Rachlis, Sharon Walmsley, Sharmistha Mishra, Sandra L Gardner, Janet Raboud, Curtis Cooper, Kevin Gough, Sean B Rourke, Rodney Rousseau, Irving Salit, Darrell H S Tan, Ann N Burchell, Vanessa G Allen, Ramandip Grewal, Paul A MacPherson, Anita Rachlis, Sharon Walmsley, Sharmistha Mishra, Sandra L Gardner, Janet Raboud, Curtis Cooper, Kevin Gough, Sean B Rourke, Rodney Rousseau, Irving Salit, Darrell H S Tan

Abstract

Background: The current syphilis epidemic among urban men who have sex with men (MSM) has serious implications for those co-infected with human immunodeficiency virus (HIV). Routine and frequent syphilis screening has the potential to ensure early detection and treatment, minimize disease burden, and help control the ongoing spread of syphilis and HIV. We aim to enhance syphilis screening among HIV-positive men by conducting a clinic-based intervention that incorporates opt-out syphilis testing into routine HIV laboratory evaluation for this population. Trial objectives are to determine the degree to which the intervention (1) increases the detection rate of untreated syphilis, (2) increases screening coverage, (3) increases screening frequency, and (4) reaches men at highest risk according to sexual behaviors.

Methods/design: The trial is a pragmatic, stepped wedge cluster-randomized controlled trial that introduces the intervention stepwise across four urban HIV clinics in Ontario, Canada. The intervention includes standing orders for syphilis serological testing whenever a male in HIV care undergoes HIV viral load testing, which typically occurs every 3-6 months. The control condition is the maintenance of current, provider-initiated syphilis testing practice. Approximately 3100 HIV-positive men will be followed over 30 months. Test results will be obtained from the centralized provincial laboratory in Ontario and will be supplemented by a standardized clinical worksheet and medical chart review at the clinics. Detailed clinical, psychosocial, and behavioral data is available for a subset of men receiving HIV care who are also participants of the province-wide Ontario HIV Treatment Network Cohort Study. Process evaluation plans include audit and feedback of compliance of the participating centers to identify potential barriers to the introduction of this type of practice into routine care. Health economic components include evaluation of the impact and cost-effectiveness of the intervention.

Discussion: This trial will be the first of its kind in Canada and will provide evidence regarding the feasibility, clinical effectiveness, and cost-effectiveness of a clinic-based intervention to improve syphilis screening among HIV-positive men. Involvement of knowledge users in all stages of trial design, conduct, and analysis will facilitate scale-up should the intervention be effective.

Trial registration: ClinicalTrials.gov NCT02019043.

Figures

Fig. 1
Fig. 1
Stepped wedge design for the Enhanced Syphilis Screening among HIV-positive Men (ESSAHM) Trial
Fig. 2
Fig. 2
Participant data collection timeline and procedures in the ESSAHM Trial

References

    1. Patton ME, Su JR, Nelson R, Weinstock H. Primary and secondary syphilis—United States, 2005–2013. Morb. Mortal. Wkly. Rep. 2014;63:402–6.
    1. Dougan S, Evans BG, Elford J. Sexually transmitted infections in Western Europe among HIV-positive men who have sex with men. Sex Transm Dis. 2007;34:783–90.
    1. The Kirby Institute. HIV, viral hepatitis and sexually transmissable infections in Australia Annual Surveillance Report 2013. The University of SoutH Wales, Sydney NSW 2052: The Kirby Institute.
    1. Verma K. P3.086 changing patterns of syphilis in Asia-pacific. Sex Transm Infect. 2013;89:A174–4.
    1. Public Health Agency of Canada . Report on sexually transmitted infections in Canada. Ottawa: Centre for Communicable Diseases and Infection Control, Infectious Disease Prevention and Control Branch; 2012.
    1. Public Health Agency of Canada . Canadian guidelines on sexually transmitted infections [Internet] Ottawa: Public Health Agency of Canada; 2010.
    1. González-López JJ, Guerrero MLF, Luján R, Tostado SF, de Górgolas M, Requena L. Factors determining serologic response to treatment in patients with syphilis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2009;49:1505–11. doi: 10.1086/644618.
    1. Tan D, Blitz S, Bensimon K, Collins M, Walmsley S. Serologic response to syphilis treatment among HIV-infected adults [Abstract] Can J Inf Dis Med Microbiol. 2011;22(Suppl SB):19B.
    1. Flood JM, Weinstock HS, Guroy ME, Bayne L, Simon RP, Bolan G. Neurosyphilis during the AIDS epidemic, San Francisco, 1985-1992. J Infect Dis. 1998;177:931–40. doi: 10.1086/515245.
    1. Rompalo AM, Joesoef MR, O’Donnell JA, Augenbraun M, Brady W, Radolf JD, et al. Clinical manifestations of early syphilis by HIV status and gender: results of the syphilis and HIV study. Sex Transm Dis. 2001;28:158–65. doi: 10.1097/00007435-200103000-00007.
    1. Rebbapragada A, Kaul R. More than their sum in your parts: the mechanisms that underpin the mutually advantageous relationship between HIV and sexually transmitted infections. Drug Discov Today Dis Mech. 2007;4:237–46. doi: 10.1016/j.ddmec.2007.12.003.
    1. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75:3–17. doi: 10.1136/sti.75.1.3.
    1. Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet. 1998;351(Suppl 3):5–7. doi: 10.1016/S0140-6736(98)90002-2.
    1. Burchell AN, Allen VG, Gardner SL, Moravan V, Tan DH, Grewal R, et al. High incidence of diagnosis with syphilis co-infection among men who have sex with men in an HIV cohort in Ontario, Canada. BMC Infect Dis. 2015;15:356. doi: 10.1186/s12879-015-1098-2.
    1. Aral S, Hogben M, Wasserheit J. STD-related health-care seeking and health service delivery. Sex. Transm. Dis. 4th ed. New York: McGraw Hill Medical; 2008. pp. 1803–20.
    1. Tuite AR, Fisman DN, Mishra S. Screen more or screen more often? Using mathematical models to inform syphilis control strategies. BMC Public Health. 2013;13:606. doi: 10.1186/1471-2458-13-606.
    1. Centers for disease control and prevention. Sexually transmitted diseases treatment guidelines [Internet]. Atlanta, GA: Centers for Disease Control and Prevention; 2010 Dec. Available from:
    1. Fakova A, Lamba H, Mackie N. 2007 UK guidelines for the management of sexual and reproductive health (SRH) of people living with HIV infection [Internet] UK: BHIVA, BASHH, FFPRHC; 2007.
    1. Tuite AR, Burchell AN, Fisman DN. Cost-effectiveness of enhanced syphilis screening among HIV-positive men who have sex with men: a microsimulation model. PLoS One. 2014;9:e101240. doi: 10.1371/journal.pone.0101240.
    1. Fairley CK, Law M, Chen MY. Eradicating syphilis, hepatitis C and HIV in MSM through frequent testing strategies. Curr Opin Infect Dis. 2014;27:56–61. doi: 10.1097/QCO.0000000000000020.
    1. Flagg EW, Weinstock HS, Frazier EL, Valverde EE, Heffelfinger JD, Skarbinski J. Bacterial sexually transmitted infections among HIV-infected patients in the United States: estimates from the Medical Monitoring Project. Sex Transm Dis. 2015;42:171–9. doi: 10.1097/OLQ.0000000000000260.
    1. Burchell AN, Allen VG, Moravan V, Gardner S, Raboud J, Tan DH, et al. Patterns of syphilis testing in a large cohort of HIV patients in Ontario, Canada, 2000–2009. BMC Infect Dis. 2013;13:246. doi: 10.1186/1471-2334-13-246.
    1. Burchell AN, Allen VG, Tan DHS, Gardner S, Moravan V, Grewal R, et al. O104 Variations in syphilis testing and diagnosis among MSM in HIV care in Ontario according to sexual behaviour. Can J Infect Med Microbiol. 2014;25:40A.
    1. Cohen CE, Winston A, Asboe D, Boag F, Mandalia S, Azadian B, et al. Increasing detection of asymptomatic syphilis in HIV patients. Sex Transm Infect. 2005;81:217–9. doi: 10.1136/sti.2004.012187.
    1. Botes LP, McAllister J, Ribbons E, Jin F, Hillman RJ. Significant increase in testing rates for sexually transmissible infections following the introduction of an anal cytological screening program, targeting HIV-positive men who have sex with men. Sex Health. 2011;8:76–8. doi: 10.1071/SH10027.
    1. Bissessor M, Fairley CK, Leslie D, Howley K, Chen MY. Frequent screening for syphilis as part of HIV monitoring increases the detection of early asymptomatic syphilis among HIV-positive homosexual men. J Acquir Immune Defic Syndr. 1999;2010;55(55):211–6.
    1. Guy R, El-Hayek C, Fairley CK, Wand H, Carr A, McNulty A, et al. Opt-out and opt-in testing increases syphilis screening of HIV-positive men who have sex with men in Australia. PLoS One. 2013;8:e71436. doi: 10.1371/journal.pone.0071436.
    1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents [Internet]. Department of Health and Human Services; 2012. Available from: .
    1. Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, et al. Antiretroviral treatment of adult hiv infection: 2014 recommendations of the international antiviral society–usa panel. JAMA. 2014;312:410–25. doi: 10.1001/jama.2014.8722.
    1. Ontario Agency for Health Protection and Promotion (Public Health Ontario) Reportable disease trends in Ontario, 2011. Toronto: Queen’s Printer for Ontario; 2014.
    1. Gesink D, Wang S, Norwood T, Sullivan A, Al-Bargash D, Shahin R. Spatial epidemiology of the syphilis epidemic in Toronto, Canada. Sex Transm Dis. 2014;41:637–48. doi: 10.1097/OLQ.0000000000000196.
    1. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007;28:182–91. doi: 10.1016/j.cct.2006.05.007.
    1. Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ. 2015;350:h391. doi: 10.1136/bmj.h391.
    1. Mdege ND, Man M-S, Taylor Nee Brown CA, Torgerson DJ. Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation. J Clin Epidemiol. 2011;64:936–48. doi: 10.1016/j.jclinepi.2010.12.003.
    1. Remis R, Swantee C, Liu J. Report on HIV/AIDS in Ontario. Toronto: Ontario HIV Epidemiologic Monitoring Unit; 2007.
    1. Myers T, Remis R, Husbands W. Technical Report: Lambda survey: M-Track Ontario second generation surveillance [Internet] 2010.
    1. Rourke SB, Gardner S, Burchell AN, Raboud J, Rueda S, Bayoumi AM, et al. Cohort profile: the Ontario HIV Treatment Network Cohort Study (OCS) Int J Epidemiol. 2013;42:402–11. doi: 10.1093/ije/dyr230.
    1. Public Health Ontario . Monthly infectious diseases surveillance report. Toronto: Public Health Ontario; 2015.
    1. Public Health Ontario Laboratory. Labstract: syphilis (Treponema pallidum) serology testing and interpretation—Update LAB-SD-057-001 [Internet]. Public Health Ontario; 2012 Oct. Available from:
    1. Meurer WJ, Lewis RJ. Cluster randomized trials: evaluating treatments applied to groups. JAMA. 2015;313:2068–9. doi: 10.1001/jama.2015.5199.
    1. Hemming K, Lilford R, Girling AJ. Stepped-wedge cluster randomised controlled trials: a generic framework including parallel and multiple-level designs. Stat Med. 2015;34:181–96. doi: 10.1002/sim.6325.
    1. Raboud J, Su D, Burchell AN, Gardner S, Walmsley S, Bayoumi AM, et al. Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study. BMC Med Res Methodol. 2013;13:31. doi: 10.1186/1471-2288-13-31.
    1. Owusu-Edusei K, Jr, Hoover KW, Tao G. Estimating the direct outpatient medical cost per episode of primary and secondary syphilis in the United States: insured population perspective, 2003-2007. Sex Transm Dis. 2011;38:175–9. doi: 10.1097/OLQ.0b013e3181f4207f.
    1. Owusu-Edusei K, Jr, Peterman TA, Ballard RC. Serologic testing for syphilis in the United States: a cost-effectiveness analysis of two screening algorithms. Sex Transm Dis. 2011;38:1–7. doi: 10.1097/OLQ.0b013e3181ec51f1.
    1. Hoch JS, Rockx MA, Krahn AD. Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of “community acquired” syncope. BMC Health Serv Res. 2006;6:68. doi: 10.1186/1472-6963-6-68.
    1. Government of Canada IAP on RE. Interagency advisory panel on research ethics [Internet]. 2010 [cited 2015 Oct 30]. Available from:

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren